» Articles » PMID: 28445303

Lifetime and Recent Alcohol Use and Bone Mineral Density in Adults with HIV Infection and Substance Dependence

Overview
Specialty General Medicine
Date 2017 Apr 27
PMID 28445303
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Low bone mineral density (BMD) is common in people living with HIV infection (PLWH), increasing fracture risk. Alcohol use is also common in PLWH and is a modifiable risk factor for both HIV disease progression and low BMD. In PLWH, alcohol's effect on BMD is not well understood.We studied adult PLWH with substance dependence. We measured lifetime alcohol use (kg) and recent (i.e., past 30-day) alcohol use (categorized as: abstinent, low risk, or high risk). In adjusted multivariable regression analyses, we tested associations between lifetime and recent alcohol use and (i) mean BMD (g/cm) at the femoral neck, total hip, and lumbar spine and (ii) low BMD diagnosis (i.e., osteopenia or osteoporosis). We also examined associations between 2 measures of past alcohol use (i.e., total consumption [kg] and drinking intensity [kg/year]) and BMD outcome measures during 3 periods of the HIV care continuum: (i) period before first positive HIV test, (ii) period from first positive HIV test to antiretroviral therapy (ART) initiation, and (iii) period following ART initiation.We found no significant associations between lifetime alcohol use and mean femoral neck (β -0.000, P = .62), total hip (β -0.000, P = .83) or lumbar spine (β 0.001, P = .65) BMD (g/cm), or low BMD diagnosis (adjusted odds ratio [aOR] = 0.98, 95% Confidence Interval [CI]: 0.95-1.01). There was no significant correlation between past 30-day alcohol use and mean BMD (g/cm). Past 30-day alcohol use was associated with low BMD diagnosis (P = .04); compared to abstainers, the aOR for high risk alcohol use was 1.94 (95% CI: 0.91-4.12), the aOR for low risk alcohol use was 4.32 (95% CI: 1.30-14.33). Drinking intensity (kg/year) between first positive HIV test and ART initiation was associated with lower mean BMD (g/cm) at the femoral neck (β -0.006, P = .04) and total hip (β -0.007, P = .02) and increased odds of low BMD (aOR = 1.18, 95% CI = 1.03-1.36).In this sample of PLWH, we detected no association between lifetime alcohol use and BMD. However, recent drinking was associated with low BMD diagnosis, as was drinking intensity between first positive HIV test and ART initiation. Longitudinal studies should confirm these associations.

Citing Articles

Heavy Alcohol Use and HIV Outcomes: The Moderating Role of Pain.

Lucero M, Palfai T, Heeren T, Stein M, Kim T, Saitz R AIDS Behav. 2024; 28(2):636-644.

PMID: 38236321 PMC: 11129659. DOI: 10.1007/s10461-023-04250-6.


Self-medication of pain and discomfort with alcohol and other substances by people with HIV infection and substance use disorder: preliminary findings from a secondary analysis.

Stein M, Godersky M, Kim T, Walley A, Heeren T, Winter M AIDS Care. 2023; 36(3):414-424.

PMID: 37909062 PMC: 10922286. DOI: 10.1080/09540121.2023.2275047.


Cannabis use frequency and pain interference among people with HIV.

Klepp T, Heeren T, Winter M, Lloyd-Travaglini C, Magane K, Romero-Rodriguez E AIDS Care. 2023; 35(8):1235-1242.

PMID: 37201209 PMC: 10332422. DOI: 10.1080/09540121.2023.2208321.


Polysubstance Use Patterns Associated With HIV Disease Severity Among Those With Substance Use Disorders: A Latent Class Analysis.

Bertholet N, Winter M, Heeren T, Walley A, Saitz R J Stud Alcohol Drugs. 2023; 84(1):79-88.

PMID: 36799677 PMC: 9948140. DOI: 10.15288/jsad.21-00440.


Testing and treatment for latent tuberculosis infection in people living with HIV and substance dependence: a prospective cohort study.

Runels T, Ragan E, Ventura A, Winter M, White L, Horsburgh C BMJ Open. 2022; 12(3):e058751.

PMID: 35273063 PMC: 8915380. DOI: 10.1136/bmjopen-2021-058751.


References
1.
Shimizu Y, Sakai A, Menuki K, Mori T, Isse T, Oyama T . Reduced bone formation in alcohol-induced osteopenia is associated with elevated p21 expression in bone marrow cells in aldehyde dehydrogenase 2-disrupted mice. Bone. 2011; 48(5):1075-86. DOI: 10.1016/j.bone.2011.01.008. View

2.
Chakkalakal D . Alcohol-induced bone loss and deficient bone repair. Alcohol Clin Exp Res. 2005; 29(12):2077-90. DOI: 10.1097/01.alc.0000192039.21305.55. View

3.
Bruera D, Luna N, David D, Bergoglio L, Zamudio J . Decreased bone mineral density in HIV-infected patients is independent of antiretroviral therapy. AIDS. 2003; 17(13):1917-23. DOI: 10.1097/00002030-200309050-00010. View

4.
Yin M . Vitamin D, bone, and HIV infection. Top Antivir Med. 2013; 20(5):168-72. PMC: 4019218. View

5.
Gill U, Zissimopoulos A, Al-Shamma S, Burke K, McPhail M, Barr D . Assessment of bone mineral density in tenofovir-treated patients with chronic hepatitis B: can the fracture risk assessment tool identify those at greatest risk?. J Infect Dis. 2014; 211(3):374-82. DOI: 10.1093/infdis/jiu471. View